Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Collignon

Showing results (231-240 of 243) with videos related to

Pageof 25
Sort By:
Molecular and Cellular Biology|May 4, 2004
The transcription factor RFX3 directs nodal cilium development and left-right asymmetry specificationE Bonnafe, M Touka, A AitLounis, et al.
Revue Medicale Suisse|October 28, 2015
[Evolution in the therapeutic strategy of localized resectable pancreatic ductal adenocarcinoma]D Van Daele, F Puleo, R Dumont, et al.
ESMO Open|May 9, 2026
Efficacy of olaparib in advanced cancers with somatic or germline mutations in BAP1, BARD1, BRIP1 and PALB2S Joris, H Denys, J Collignon, et al.
ESMO Open|October 18, 2023
Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II studyS Joris, H Denys, J Collignon, et al.
Revue Medicale De Liege|August 11, 2011
[Hormone therapy for breast cancer]E Lifrange, C Andre, V Bleret, et al.
Communicable Diseases Intelligence Quarterly Report|January 30, 2015
Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013Geoffrey W Coombs, Graeme R Nimmo, Denise A Daly, et al.
Acta Gastro-Enterologica Belgica|March 22, 2018
A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice updateR Dumont, F Puleo, J Collignon, et al.
Acta Gastro-Enterologica Belgica|July 20, 2018
WITHDRAWN: A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice updateR Dumont, F Puleo, J Collignon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2026
Trastuzumab deruxtecan in hormone receptor-positive, HER2-low/-ultralow metastatic breast cancer (DESTINY-Breast06): outcome analyses by time to progression on prior first-line endocrine therapy with CDK4/6 inhibitor and baseline burden of diseaseG Curigliano, X Hu, R Dent, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2016
World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies to Control Antimicrobial Resistance From Food Animal ProductionPeter J Collignon, John M Conly, Antoine Andremont, et al.
Pageof 25

Showing results (231-240 of 243) with videos related to

Sort By:
Pageof 25
Molecular and Cellular Biology|May 4, 2004
The transcription factor RFX3 directs nodal cilium development and left-right asymmetry specificationE Bonnafe, M Touka, A AitLounis, et al.
Revue Medicale Suisse|October 28, 2015
[Evolution in the therapeutic strategy of localized resectable pancreatic ductal adenocarcinoma]D Van Daele, F Puleo, R Dumont, et al.
ESMO Open|May 9, 2026
Efficacy of olaparib in advanced cancers with somatic or germline mutations in BAP1, BARD1, BRIP1 and PALB2S Joris, H Denys, J Collignon, et al.
ESMO Open|October 18, 2023
Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II studyS Joris, H Denys, J Collignon, et al.
Revue Medicale De Liege|August 11, 2011
[Hormone therapy for breast cancer]E Lifrange, C Andre, V Bleret, et al.
Communicable Diseases Intelligence Quarterly Report|January 30, 2015
Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013Geoffrey W Coombs, Graeme R Nimmo, Denise A Daly, et al.
Acta Gastro-Enterologica Belgica|March 22, 2018
A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice updateR Dumont, F Puleo, J Collignon, et al.
Acta Gastro-Enterologica Belgica|July 20, 2018
WITHDRAWN: A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice updateR Dumont, F Puleo, J Collignon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2026
Trastuzumab deruxtecan in hormone receptor-positive, HER2-low/-ultralow metastatic breast cancer (DESTINY-Breast06): outcome analyses by time to progression on prior first-line endocrine therapy with CDK4/6 inhibitor and baseline burden of diseaseG Curigliano, X Hu, R Dent, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2016
World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies to Control Antimicrobial Resistance From Food Animal ProductionPeter J Collignon, John M Conly, Antoine Andremont, et al.
Pageof 25